Hydroxyurea 500 MG Oral Capsule — RxCUI 197797
RxNorm drug concept · Semantic clinical drug
RxCUI 197797
Semantic clinical drug · SCD
● Current RxNorm concept 12 FDA products
12 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI197797
Official nameHydroxyurea 500 MG Oral Capsule
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped12
Package NDCs mapped12
Reported Medicaid activity (SDUD)111,994 prescriptions · 50 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Hydroxyurea: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- It's actually both, depending on the specific product. Droxia, Siklos, and Xromi are each approved to reduce the painful crises and blood transfusion needs in sickle cell anemia. H...
- What exactly is hydroxyurea used for — is it a cancer drug or a sickle cell drug?
- Very regularly — typically every two weeks while your dose is being adjusted. Hydroxyurea can lower your white blood cell and platelet counts, so monitoring is built into the treat...
- How often will I need blood tests while I'm on this medication?
🕸️ Concept Web — How Hydroxyurea 500 MG Oral Capsule Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Hydroxyurea 500 MG Oral Capsule
RxCUI 197797 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Hydroxyurea
5552IN
-
Hydroxyurea
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Hydrea
151871BN
-
Hydrea
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Hydroxyurea Oral Capsule
370658SCDF -
Hydroxyurea Oral Product
1160113SCDG -
Hydroxyurea Pill
1160114SCDG -
Hydroxyurea Oral Capsule [Hydrea]
366743SBDF -
Hydrea Oral Product
1174066SBDG -
Hydrea Pill
1174067SBDG -
Oral Capsule
316965DF -
Oral Product
1151131DFG - +1 more in this family
-
Hydroxyurea Oral Capsule
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Hydroxyurea 500 MG
316070SCDC -
Hydroxyurea 500 MG Oral Capsule [Hydrea]
105602SBD -
Hydroxyurea 500 MG [Hydrea]
564113SBDC
-
Hydroxyurea 500 MG
Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Hydroxyurea 500 MG
SCDC · 316070 -
Hydroxyurea Oral Capsule
SCDF · 370658 -
Hydroxyurea Oral Product
SCDG · 1160113 -
Hydroxyurea Pill
SCDG · 1160114
Brand-Name Concepts
-
Hydroxyurea 500 MG Oral Capsule [Hydrea]
SBD · 105602 -
Hydroxyurea 500 MG [Hydrea]
SBDC · 564113 -
Hydroxyurea Oral Capsule [Hydrea]
SBDF · 366743 -
Hydrea Oral Product
SBDG · 1174066 -
Hydrea Pill
SBDG · 1174067 -
Hydrea
BN · 151871
📦 FDA Products & Package NDCs
12 products · 12 package NDCs
12 package NDCs map to RxCUI 197797 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00555-0882-02 | 100 CAPSULE in 1 BOTTLE (0555-0882-02) | HYDROXYUREA | Teva Pharmaceuticals USA, Inc. | 1998-10-19 |
| 00904-6939-61 | 100 BLISTER PACK in 1 CARTON (0904-6939-61) / 1 CAPSULE in... | Hydroxyurea | Major Pharmaceuticals | 1999-02-24 |
| 42291-0321-01 | 100 CAPSULE in 1 BOTTLE (42291-321-01) | HYDROXYUREA | AvKARE | 2013-07-23 |
| 49884-0724-01 | 100 CAPSULE in 1 BOTTLE (49884-724-01) | Hydroxyurea | Par Health USA, LLC | 1999-02-24 |
| 51407-0909-01 | 100 CAPSULE in 1 BOTTLE, PLASTIC (51407-909-01) | HYDROXYUREA | Golden State Medical Supply, Inc. | 2024-04-22 |
| 61269-0835-10 | 100 CAPSULE in 1 BOTTLE (61269-835-10) | HYDREA | H2-Pharma LLC | 2009-06-01 |
| 67046-1619-03 | 30 CAPSULE in 1 BLISTER PACK (67046-1619-3) | HYDROXYUREA | Coupler LLC | 2025-12-02 |
| 67184-0607-01 | 100 CAPSULE in 1 BOTTLE (67184-0607-1) | HYDROXYUREA | Qilu Pharmaceutical Co., Ltd. | 2024-03-06 |
| 68084-0284-01 | 100 BLISTER PACK in 1 BOX, UNIT-DOSE (68084-284-01) / 1 CAP... | Hydroxyurea | American Health Packaging | 2008-09-17 |
| 69315-0164-01 | 100 CAPSULE in 1 BOTTLE, PLASTIC (69315-164-01) | HYDROXYUREA | Leading Pharma, LLC | 2020-07-09 |
| 70069-0820-01 | 100 CAPSULE in 1 BOTTLE (70069-820-01) | HYDROXYUREA | Somerset Therapeutics, LLC | 2024-06-18 |
| 80725-0810-10 | 100 CAPSULE in 1 BOTTLE, PLASTIC (80725-810-10) | HYDREA | Waylis Therapeutics LLC | 2025-09-11 |
Observed labelers:
American Health Packaging (1) ·
AvKARE (1) ·
Coupler LLC (1) ·
Golden State Medical Supply, Inc. (1) ·
H2-Pharma LLC (1) ·
Leading Pharma, LLC (1)
· +6 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
💲 Pricing (NADAC)
NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.
Per ea · median
$0.1910
Range $0.1910–$0.1910
· middle 50% $0.1910–$0.1910
· 6 NDCs
Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.